FUNDING
Company Profile
Chai Discovery builds generative AI foundation models that predict and design protein and antibody structures to accelerate pre-clinical drug discovery.
Founded 2024San Francisco, CA$600M raised$3.8B valuation
Investors
Index VenturesSequoia CapitalDimensionKleiner Perkins
Compare with
Funding & Valuation History
from our coverage| Date | Event | Amount | Valuation | Source |
|---|---|---|---|---|
| Jul 17, 2026 | Chai Discovery Raises $400M at $3.8B for AI Drug Design | $400M at $3.8B | $3.8B | Story → |
Chai Discovery FAQ
- What is Chai Discovery's valuation in 2026?
- Chai Discovery was last valued at $3.8B in its most recent funding round.
- How much has Chai Discovery raised?
- Chai Discovery has raised approximately $600M in total funding to date.
- Is Chai Discovery publicly traded?
- No. Chai Discovery is privately held, last valued at $3.8B.
- Who are Chai Discovery's investors?
- Chai Discovery's investors include Index Ventures, Sequoia Capital, Dimension, Kleiner Perkins.
Coverage Timeline
newest firstAll Coverage
FUNDING$800M Fund III
Dimension Capital Raises $800M Third Fund for Science-Compute Bets
Dimension Capital closed an $800 million third fund, 60% larger than its prior vehicle, betting on the intersection of biotech and AI compute after early wins including Chai Discovery's jump to a $3.8 billion valuation.
FUNDING
Chai Discovery Raises $400M at $3.8B for AI Drug Design
FUNDING$400M at $3.8B
Chai Discovery Raises $400M at $3.8B for AI Drug Design
Life-sciences AI startup Chai Discovery raised a $400 million Series C at a $3.8 billion valuation led by Index Ventures, Sequoia, Dimension and Kleiner Perkins, one of the largest rounds yet for AI-driven drug and molecule design.